esophagus cancer
Conditions
Interventions
Case series:to receive concomitant radiochemotherapy with pemetrexed + cisplatin: pemetrexed 400mg/m2, i.v. drip d1
cisplatin 10mg/m2, i.v. drip d1 -5. Radiotherapy carried out in the 1st and 4th week
Sponsors
Shandong Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Signed informed consent; 2. Acquired pathological diagnosis; 3. Life expectancy>=6 months; 4. Age: 18-75 years, male or female; 5. General state of health: ECOG 0-1 grade; 6. Without any chemotherapy or radiotherapy; 7. Subjects meet the following criteria for the clinical laboratory: HG>=100g/L, WBC>=3.5*10^9/L, neutrophilic leukocyte>=1.5*10^9, PLT 10*10^9 /L, CR<=1.5*N, TB<=2.5*N, AST and ALT<=2.5*N, AKP<=2.5*N.
Exclusion criteria
Exclusion criteria: 1. Serious infection; 2. Uncontrollable diabetes; 3. Other serious diseases, such as myocardial infarction in 6 months; 4. Participated other clinical trials in 4 weeks or at present.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response rate; | — |
Countries
China
Contacts
Public ContactBaosheng Li
Outcome results
None listed